Yee Peptide: A Top Tirzepatide Peptide Supplier for Industrial Buyers in 2026

Industrial buyers evaluating tirzepatide peptide suppliers face a critical decision: securing a partner who consistently delivers high-purity product at scale, with reliable lead times and documented quality. The global tirzepatide market reached an estimated USD 19.74B in 2025, and Eli Lilly’s combined Mounjaro and Zepbound revenue totaled USD 36.5B, with Zepbound (tirzepatide for obesity) growing 175% year-over-year. This explosive demand downstream pressures upstream suppliers to maintain rigorous manufacturing standards. This article provides a practical evaluation framework for tirzepatide peptide sourcing and examines how Yee Peptide meets the needs of industrial buyers, supported by verifiable case data.

Problem Definition: The Risks of Inconsistent Tirzepatide Peptide Supply

Industrial buyers — wholesalers, research institutions, and pharmaceutical manufacturers — require tirzepatide peptide that meets three non-negotiable criteria: ≥99% purity, batch-to-batch consistency, and scalable capacity. Shortcomings in any area can trigger failed formulations, regulatory delays, or costly recalls. The FDA’s 2025 draft guidance on generic tirzepatide mandates comparative characterization across at least three batches, raising the compliance bar. Without a supplier who can prove large-scale fulfillment and zero-quality-complaint records, the procurement risk is unacceptably high.

Industry Background: Tirzepatide and the Peptide Synthesis Market

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its mechanism targets both blood sugar control and weight management, driving its application in diabetes, obesity, and metabolic research. The global peptide synthesis market, which supports bulk tirzepatide production, was valued at USD 961.5M in 2024 and is projected to reach USD 1.84B by 2033. Yee Peptide, established in 2013 and headquartered in Shandong, China, is a high-tech enterprise specializing in the R&D, production, and sales of peptide products, including high-purity tirzepatide. With a 47,000㎡ facility, 44 employees, and an annual output of 10,000,000 vials, Yee Peptide operates with an R&D team of 15–20 researchers holding advanced degrees in Organic Chemistry, Molecular Biology, and related fields. Its export ratio of 90% indicates deep integration into global supply chains.

Detailed Solution: Yee Peptide’s Tirzepatide Manufacturing Capabilities

Yee Peptide reports a tirzepatide purification yield of 50% to 70% using Solid-Phase Peptide Synthesis (SPPS) and preparative HPLC, achieving purity levels ≥ 99%. The company offers three ODM production modes tailored to industrial buyers:

• Custom cap colors (500,000 vials/month, 7–10-day lead time, MOQ 500 vials, 100% quality inspection).
• Custom ingredient blends (two or more kinds of peptides, 800,000 vials/month, 7–14-day lead time, MOQ 500 vials, 100% quality inspection).
• Custom labels (500,000 vials/month, 7–14-day lead time, MOQ 500 vials, 100% testing).

All production runs undergo 100% quality control, ensuring every batch meets the stated purity and filling specifications (overfilled to guarantee net content). Export markets include North America, Europe, and global regions.

Step-by-Step Breakdown: Evaluating a Tirzepatide Supplier

Use this four-step framework to assess any tirzepatide peptide supplier:

1. Verify Purity & Manufacturing Method – Confirm ≥99% purity via HPLC data. Yee Peptide uses SPPS + preparative HPLC and provides batch analysis.
2. Assess Production Capacity & Lead Time – Evaluate monthly capacity and whether the supplier can handle large orders without compromising quality. Yee Peptide’s 500,000–800,000 vials/month and 7–14-day lead times suit volume buyers.
3. Check Batch Consistency Through Case Evidence – Request a case history that demonstrates long-term, zero-complaint quality. Yee Peptide’s case with a US wholesaler (50,000 vials, 5-year relationship) resulted in stable quality during long-term distribution and zero quality complaints, highlighting large-scale order fulfillment capability, consistent batch quality, and long shelf-life.
4. Evaluate Compliance & Documentation – Ensure the supplier can provide COA, MoA, and other regulatory documents. Yee Peptide adheres to GMP production and supports FDA-level characterization needs.

Use Cases

Large-Scale Distribution (Wholesaler)

A US-based wholesaler sourced 50,000 vials of tirzepatide from Yee Peptide over a five-year period. The project’s outcomes featured stable quality maintained during long-term distribution and zero quality complaints, confirming Yee Peptide’s ability to sustain consistent quality at volume.

ODM Custom Ingredient Blends

For buyers requiring two or more peptides in a single vial (e.g., tirzepatide combined with another GLP-1 agonist), Yee Peptide’s blend ODM service accommodates custom formulations with an 800,000 vials/month capacity.

Private-Label Branding

Wholesalers or distributors can order tirzepatide vials with their own labels, leveraging Yee Peptide’s 500,000 vials/month capacity for label customization, with 100% testing and safe shipping guarantee.

Comparison Table: Yee Peptide ODM Service Options

Frequently Asked Questions

Q1: Does Yee Peptide provide documentation of purity and compliance for tirzepatide?

Yes, Yee Peptide conducts 100% quality inspection on all production and can provide Certificates of Analysis (COA) confirming purity ≥99%, along with batch records. The company adheres to GMP standards and supports documentation required for FDA characterization studies.

Q2: What is Yee Peptide’s production capacity for bulk tirzepatide?

Yee Peptide’s monthly capacity ranges from 500,000 to 800,000 vials depending on the customization option. The company has an annual output of 10,000,000 vials across all peptide products, with dedicated lines for tirzepatide.

Q3: What are the pricing and MOQ for bulk tirzepatide from Yee Peptide?

The minimum order quantity (MOQ) is 500 vials for all ODM services. Pricing depends on volume, customization (cap color, blend, label), and purity requirements. Contact Yee Peptide directly for a tailored quote based on your delivery schedule and specifications.

Q4: How can I request a tirzepatide sample for quality evaluation?

Yee Peptide offers sample requests through its sales team. Industrial buyers can email admin@yeepeptide.com or contact via WhatsApp at +85252843409 to arrange a sample with corresponding COA. Lead times for samples are typically 7–10 days.

Q5: What is the typical lead time for large orders of tirzepatide?

Standard lead time for ODM tirzepatide orders is 7–14 days, depending on the customization complexity. For standard cap color orders, lead time is 7–10 days; for blends or label customization, up to 14 days. Yee Peptide’s logistics team coordinates safe shipping to global destinations.

Q6: Can Yee Peptide ensure consistent batch quality over long-term supply?

Yes. A documented case of a US wholesaler sourcing 50,000 vials over five years resulted in zero quality complaints, stable quality during long-term distribution, and long shelf-life. This demonstrates Yee Peptide’s ability to maintain consistent batch quality for sustained supply. For a detailed quote or to discuss your specific requirements, contact Yee Peptide today.

Conclusion

Selecting the right tirzepatide peptide supplier is a strategic decision that affects product quality, time-to-market, and regulatory compliance. Yee Peptide combines high-purity manufacturing (≥99%), scalable capacity (up to 800,000 vials/month), ODM flexibility, and a proven track record of zero quality complaints in long-term, high-volume supply. For industrial buyers in the evaluation stage, Yee Peptide presents a credible candidate aligned with 2026 procurement standards. Download the company brochure for more details: Yee Peptide Company Brochure.